DGAP-News: Alzchem Group AG
/ Key word(s): Market Report
Alzchem positions itself in e-mobility in the fuel cell sector as a technology provider in the production of hydrogen tanks
Trostberg, December 1, 2021 - Alzchem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, intends to intensify its penetration of the e-mobility market in the field of fuel cells. The aim is to position itself as an important solution provider in the manufacturing process of hydrogen tanks, which are among the key components of this strong future drive type due to their high pressure resistance. Based on its already highly successful additives for the composites industry, Alzchem has developed a technological all-in-one solution for more efficient fiber winding of carbon fiber-reinforced hydrogen pressure cylinders in order to offer manufacturers here significant advantages in processing, surface quality and quality control. Andreas Niedermaier, CEO of Alzchem Group AG: "With our DYHARD(R) Fluid System, we are addressing all types of e-mobility based on fuel cell technology, i.e. primarily commercial vehicles, maritime solutions and rail transport. This is where we first expect the breakthrough for fuel cell technology. However, we are also in discussions with manufacturers in the mass automotive market. Even the aircraft industry is working on H2 propulsion systems. Our goal is to establish our solution in the manufacturing process of high-performance H2 pressure cylinders as a key component in the market. We are currently talking to all pressure cylinder manufacturers in the world, German and European as well as Asian and American manufacturers." In heavy-duty transport in particular, ambitious fleet targets are increasing the development pressure on automobile manufacturers. Hydrogen propulsion is seen as a solution and a quantum leap. Alzchem is already working here with several OEMs in markets where technology is at the forefront. In Japan and South Korea in particular, trucks with fuel cell propulsion systems are already marketable. An expanded product range for market entry in Europe will follow. The goal of a German automotive group is to sell only zero-emission commercial vehicles in Japan, North America, Mexico and Europe by the end of the decade. The maritime sector is also an interesting market for Alzchem. Alongside Germany and an American-British cooperation, Scandinavia is a pioneer in hydrogen in the maritime segment. Another target market for fuel cell technology and thus hydrogen pressure cylinders will be rail transport. The world's first H2 trains are already in operation on the German rail network. Diesel locomotives will also increasingly be replaced on non-electrified lines in favor of zero-emission trains. Dr. Georg Weichselbaumer, CSO of Alzchem Group AG: "Manufacturers such as Daimler or Bosch pay attention to a high level of in-house value creation in fuel cell technology and want to cover many components themselves. With our solution, we enable the hydrogen pressure cylinders to be manufactured as efficiently as possible, but at the same time, we are not dependent on the respective technology or the specific fuel cell system. This enables us to address the entire market spectrum of e-mobility based on fuel cell technology. We want to make a contribution so that this environmentally friendly technology penetrates the transportation sector as quickly as possible and improves its CO2 balance quite significantly." About Alzchem The company sees interesting growth prospects for itself especially in the areas of human and animal nutrition and agriculture. As a result of population growth, it is necessary to achieve efficient food production. Pharmaceutical raw materials and our creatine products can contribute to healthy aging as life expectancy increases. Alzchem is facing up to the goal of sustainability arising from climate change in the field of renewable energies and across the entire company. The fields of fine chemicals and metallurgy offer just as great a perspective. The broad product range of Alzchem Group AG includes dietary supplements, precursors for corona tests and pharmaceutical raw materials. These products are our company's response to global trends and developments. Alzchem is ideally positioned in this regard and sees itself as well equipped for an environmentally oriented future and global developments. The company employs around 1,630 people at four production sites in Germany and one plant in Sweden, as well as two sales companies in the USA and China. In 2020, Alzchem generated consolidated sales of around EUR 379 million and EBITDA of around EUR 53.8 million.
01.12.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | Alzchem Group AG |
Dr.-Albert-Frank-Str. 32 | |
83308 Trostberg | |
Germany | |
Phone: | +498621862888 |
Fax: | +49862186502888 |
E-mail: | ir@alzchem.com |
Internet: | www.alzchem.com |
ISIN: | DE000A2YNT30 |
WKN: | A2YNT3 |
Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart |
EQS News ID: | 1253427 |
End of News | DGAP News Service |
|
1253427 01.12.2021
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.